Stay updated on Nivolumab Combo Therapy in Virus Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page.
Latest updates to the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe website has added FDA Safety Alerts and Recalls with the new revision v2.11.2, replacing the previous revision v2.11.0.SummaryDifference0.2%
- Check16 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference0.8%
- Check23 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.7%
- Check38 days agoChange DetectedThe website has been updated to version 2.10.3, which includes new features, while the FDA Safety Alerts and Recalls section from version 2.10.2 has been removed.SummaryDifference0.2%
- Check59 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check80 days agoChange DetectedThe study has expanded to include 40 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
Stay in the know with updates to Nivolumab Combo Therapy in Virus Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Therapy in Virus Tumors Clinical Trial page.